Study of an experimental drug for weight and diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational drug called GS-4571 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects the body and whether it might help with weight and blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old, depending on the part of the study.
- You have not taken GLP-1 medicines (like Ozempic or Wegovy) in the last 6 months.
- You are either healthy, have obesity (BMI 30-45), or have type 2 diabetes with a BMI under 30.
- You have no serious medical conditions like heart disease, pancreatitis, or active infections.
- You have not had significant weight changes in the last 3 months (if you have obesity).
- You are not currently taking certain medications like steroids or immunosuppressants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.
Hear when a new Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.